Nemonoxacin achieved a better symptomatic improvement and a prolonged interval to next exacerbation than moxifloxacin for outpatients with acute exacerbations of chronic obstructive pulmonary disease

Citation counts are provided by Dimensions and depend on their data availability. Counts will update daily, once available.